Related Experiment Video
Updated: Jan 10, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Prostate Cancer Mortality Trend in Montenegro 1990-2018
Mirjana Nedovic Vukovic1,2, Milos Bojic2,3, Marina Jaksic2,4
1Center for Health System Evidence and Research in Public Health, Institute of Public Health of Montenegro, Podgorica, Montenegro.
Prostate cancer mortality in Montenegro significantly increased by 2.4% annually from 1990-2018, particularly in men aged 75-84. This highlights an urgent need for enhanced prevention and early detection strategies.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Prostate cancer is a leading cause of cancer death globally, responsible for significant mortality in numerous countries.
- In 2020, prostate cancer caused an estimated 375,304 deaths worldwide, with a mortality rate of 7.7 per 100,000 men.
- It is the primary cause of cancer mortality in 48 countries, underscoring its global health impact.
Purpose of the Study:
- To analyze the prostate cancer mortality trends in Montenegro.
- To assess the changes in prostate cancer mortality rates between 1990 and 2018.
- To identify specific age groups most affected by prostate cancer mortality in Montenegro.
Main Methods:
- Utilized regression techniques, including joinpoint, linear, and Poisson regression, for trend assessment.
- Collected and analyzed prostate cancer mortality data for Montenegro spanning from 1990 to 2018.
- Applied age-standardization to the World Standard Population for accurate trend estimation.
Main Results:
- A total of 1,184 prostate cancer deaths were recorded in Montenegro between 1990 and 2018.
- Prostate cancer mortality rates showed a statistically significant annual increase of 2.4% (AAPC=2.4%, P<0.001).
- Mortality rates increased significantly in men aged 75-84 (2.7% annually, P<0.001) and non-significantly in men aged 65-74 (1.1% annually, P=0.452).
Conclusions:
- The observed increasing trend in prostate cancer mortality necessitates improved prevention, screening, and early diagnosis measures.
- Special attention should be directed towards older male populations, particularly those aged 75 and above.
- Effective treatment strategies must be enhanced to address the rising mortality rates in Montenegro.
Related Concept Videos
Cancer Survival Analysis
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

